Tag: Revefenacin

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Revefenacin

Theravance Biopharma to Participate in an Upcoming Investor Conference

Added to Collection on: 2024-07-25 10:01:00

Tags for this article:

Life Sciences
Biotechnology
Chemical compounds
Benzamides
Carbamates
Piperidines
Revefenacin
Biopharmaceutical
Innoviva Inc

Click the tags to see associated articles and topics

View Article Details
Theravance Biopharma to Report Second Quarter 2021 Financial Results on August 3, 2021

Added to Collection on: 2021-07-20 09:56:15

Tags for this article:

Chemical compounds
Benzamides
Bronchodilators
Carbamates
Piperidines
Revefenacin
Organic compounds
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
THERAVANCE BIOPHARMA, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF ...

Added to Collection on: 2022-05-07 09:03:19

Tags for this article:

Health sciences
Health
Medicine
Respiratory therapy
Dosage forms
Chronic lower respiratory diseases
Chronic obstructive pulmonary disease
Revefenacin
Asthma
Idiopathic pulmonary fibrosis
Viatris
Inhaler

Click the tags to see associated articles and topics

View Article Details
Theravance Biopharma (TBPH) to Sell Trelegy Royalty Interests - July 14, 2022 - Zacks.com

Added to Collection on: 2022-07-14 21:39:57

Tags for this article:

Drugs
Ellipta
Chemical compounds
Carbamates
Fluticasone furoate/vilanterol
Royalty payment
Medicine
Revefenacin
Trelegy
Breo Ellipta
royalty pharma
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
Theravance Finds Creative Solution to Recent Woes with $1.31B Royalty Payday

Added to Collection on: 2022-07-14 19:02:23

Tags for this article:

Pulmonology
Health care
Clinical medicine
Respiratory therapy
Muscarinic antagonists
Bronchodilators
Chronic lower respiratory diseases
Ellipta
Combination drugs
Vilanterol
Revefenacin
Fluticasone furoate/umeclidinium bromide/vilanterol
THERAVANCE
Theravance Biopharma
royalty pharma

Click the tags to see associated articles and topics

View Article Details
Theravance Biopharma, Inc. Initiates $250 Million Capital Return Program - PR Newswire

Added to Collection on: 2022-09-19 10:00:58

Tags for this article:

Stock market
Economy
Financial economics
Finance
Corporate finance
Financial reporting
SEC filing
Share repurchase
Tender offer
Forward-looking statement
Short
Revefenacin
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
Theravance Biopharma, Inc. Announces Preliminary Results of Tender Offer - PR Newswire

Added to Collection on: 2022-11-18 11:01:00

Tags for this article:

Stock market
Economy
Finance
Financial economics
Corporate finance
Financial regulation
Short
Forward-looking statement
Share repurchase
Revefenacin
Dutch auction
Security
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
2023-11-07 | NDAQ:TBPH | Press Release | Theravance Biopharma Inc - Stockhouse

Added to Collection on: 2023-11-07 22:07:34

Tags for this article:

United States Generally Accepted Accounting Principles
Financial statements
Viatris
Mylan
Income statement
Employee stock option
Revefenacin
Gain
Orthostatic hypotension
Teva Pharmaceuticals
Income
BlackBerry Limited
Ellipta
United States
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
Theravance Biopharma to Conduct Investor Meetings During the J.P. Morgan 42nd Annual ...

Added to Collection on: 2023-12-18 23:04:38

Tags for this article:

Benzamides
Bronchodilators
Carbamates
Piperidines
Revefenacin
Viatris
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details
Theravance Biopharma Reports Q2 2024 Financial Results - TradingView

Added to Collection on: 2024-08-05 20:59:42

Tags for this article:

Benzamides
Bronchodilators
Carbamates
Piperidines
Revefenacin
.net
Revenue
Theravance Biopharma Inc

Click the tags to see associated articles and topics

View Article Details